Page 5 - Revbio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revbio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revbio Inc Today - Breaking & Trending Today

RevBio, Inc.: RevBio Receives Approval from the U.K.'s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

RevBio, Inc.: RevBio Receives Approval from the U.K.'s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Alan Pollack , Revbio Tetranite , Kostenloser Wertpapierhandel , Michael Tiedemann , Michaelr Norton , Academy Of Osseointegration , Revbio Inc , Regulatory Agency , Revbio Receives Approval , Clinical Trial , Modified Formulation , Bone Adhesive Biomaterial , Business Wire , Senior Director , Dental Clinical ,

RevBio Receives Approval from the U.K.'s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

RevBio Receives Approval from the U.K.'s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Alan Pollack , Revbio Tetranite , Michael Tiedemann , Michaelr Norton , Academy Of Osseointegration , Revbio Inc , Regulatory Agency , Bio Receives Approval , Clinical Trial , Modified Formulation , Bone Adhesive Biomaterial , Business Wire , Senior Director , Dental Clinical ,

RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology


RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology
This Grant will Fund the Completion of the Company s Pre-Clinical Research Paving the Way to Initiate a Clinical Study for this Indication.
News provided by
Share this article
Share this article
LOWELL, Mass., April 6, 2021 /PRNewswire/ RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite ....

United States , Revbio Tetranite , Brian Hess , Rick Gennett , Revbio Inc , National Institute On , National Institute , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஹெஸ் , தேசிய நிறுவனம் ஆன் , தேசிய நிறுவனம் ,